Figure 5. cfDNA profile distinguishes patients with COVID-19 by outcomes.

Receiver operating characteristic (ROC) curve analysis of cfDNA measures early at admission as predictor and COVID-19 outcomes categorized as hospitalized recovered and deceased: (A) ncfDNA, (B) mtcfDNA, (C) monocyte-derived cfDNA, (D) neutrophil-derived cfDNA, (E) erythroblast-derived cfDNA, (F) vascular endothelium–derived cfDNA, (G) adipocyte-derived cfDNA, (H) hepatocyte-derived cfDNA, (I) pancreas-derived cfDNA, (J) bladder-derived cfDNA, (K) kidney-derived cfDNA, (L) heart-derived cfDNA, and (M) lung-derived cfDNA.